Bausch Health
BHC
#4214
Rank
$2.57 B
Marketcap
$6.93
Share price
-6.10%
Change (1 day)
-18.09%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): $0.97

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is $0.97. In 2024 the company made an earnings per share (EPS) of -$0.12 an increase over its 2023 EPS that were of -$1.62.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$0.97-908.33%
2024-$0.12-92.59%
2023-$1.62160.89%
2022-$0.62-76.64%
2021-$2.6668.45%
2020-$1.58-68.91%
2019-$5.07-57.11%
2018-$11.83-272.22%
2017$6.87-199.29%
2016-$6.92798.7%
2015-$0.77-128.31%
2014$2.72-204.62%
2013-$2.60602.7%
2012-$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-$0.95-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-$0.24-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA